Birmingham, West Midlands -- (SBWIRE) -- 12/20/2013 -- Value Penny Stocks issues special report on Iridium Communications Inc. (NASDAQ:IRDM), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Athersys, Inc. (NASDAQ:ATHX).
Iridium Communications Inc. (NASDAQ:IRDM) opened its last trade at the price of $5.70. Its closing price was $5.90 after gaining 4.06% for the day. The company traded with the total volume of 2,194,435 shares, while its average trading volume remained 944,584.00 shares. The beta of this stock stands at 0.37. Iridium Communications Inc. provides mobile voice and data communications services through satellites to businesses, the U.S. and foreign governments, non-governmental organizations, and consumers worldwide.
For How Long IRDM will Fight for Profitability? Read This Trend Analysis report
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) percentage change plunged -1.80% to close at $4.92 with the total traded volume of 2,192,943 shares, along with average volume of 2.72 million shares. The 52 week range of the stock remained $2.05 - $7.09, while its day lowest price was $4.89. The share price hit the day highest price of $5.16. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Has MACK Found The Bottom And Ready To Gain Momentum? Find Out Here
Athersys, Inc. (NASDAQ:ATHX) traded on volume of 2,214,517 shares in the last session against average volume of 910,006.00 shares. The company started its trading session with the price of $2.08 and closed at $2.12 by scoring +2.91%. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company?s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine.
Will ATHX Continue To Move Higher? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)